Vast amounts of information on medicines is available, especially online, but it is very hard to know what is reliable or even relevant for a specific patient. And, while each medicine comes with a detailed information leaflet, patients often find these difficult to read and understand.
The aim of Gravitate-Health is to develop a digital health information tool called the Gravitate Lens (G-Lens). As the name suggests, the G-Lens will focus (but not conceal or filter) approved information on medicines and guide patients to understandable, trustworthy, up-to-date information that meets the patient’s needs and fits with their health context and literacy levels. The functionality of the G-Lens will be supported by an open source digital platform.
In addition to the open source platform underlying the G-Lens, the project will produce a white paper on the future use of digital services like electronic product information can be used to further minimise the risks associated with incorrect adherence to advice on medicines.
Gravitate Health will deliver an open source digital platform supporting G-Lens functionally, demonstrated in a number of testing scenarios, and a White Paper with recommendations on realistic strategies to strengthen access, understanding and future use of digital services like electronic production information (ePI) as a tool for Risk Minimization.
Gravitate Health services and G-lens will be developed and tested within the project, using an evaluation framework to test the efficiency, efficacy, and safety of Gravitate-Health services.
Gravitate Health’s main objectives are:
1 – to develop an integrated, digital, user-centric health information solution with two-way communication for the public, so that health information from a set of trusted sources is available and understandable, such as the package leaflet content and EHR-IPS (International Patient Summary).
2 – to promote adherence to treatment, safer use of medication (Pharmacovigilance), better health outcomes and quality of life through improved availability and understanding of health information.
The Gravitate Health is a public – private partnership with 40 members from Europe and the US, co-led by University of Oslo (coordinator) and Pfizer (industry lead), funded by the Innovative Medicines Initiative (IMI) – a joint undertaking of the European Commission, the European Federation of Pharmaceutical Industries and Associations (EFPIA), IMI Associated Partners.
The full list of partners is available here.